Edge Wealth Management’s Biogen BIIB Stock Holding History

Edge Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5	Closed	-$1K	–	146
2021 Q4	$1K	Hold	5	–	–	﹤0.01%	453
2021 Q3	$1K	Buy	+5	New	+$1.64K	﹤0.01%	471
2019 Q4	–	Sell	-250	Closed	-$58K	–	602
2019 Q3	$58K	Hold	250	–	–	0.01%	237
2019 Q2	$58K	Hold	250	–	–	0.01%	244
2019 Q1	$59K	Buy	+250	New	+$78.7K	0.01%	227
2018 Q2	–	Sell	-300	Closed	-$82K	–	592
2018 Q1	$82K	Buy	+300	New	+$93.1K	0.02%	179
2017 Q2	–	Sell	-210	Closed	-$57K	–	543
2017 Q1	$57K	Hold	210	–	–	0.02%	200
2016 Q4	$60K	Buy	210 +125	+147%	+$37.1K	0.02%	175
2016 Q3	$27K	Hold	85	–	–	0.01%	240
2016 Q2	$21K	Hold	85	–	–	0.01%	249
2016 Q1	$22K	Hold	85	–	–	0.01%	221
2015 Q4	$26K	Hold	85	–	–	0.01%	225
2015 Q3	$24K	Buy	+85	New	+$28.1K	0.01%	226
2015 Q1	–	Sell	-10	Closed	-$3K	–	460
2014 Q4	$3K	Hold	10	–	–	﹤0.01%	363
2014 Q3	$3K	Hold	10	–	–	﹤0.01%	361
2014 Q2	$3K	Hold	10	–	–	﹤0.01%	337
2014 Q1	$3K	Hold	10	–	–	﹤0.01%	346
2013 Q4	$3K	Hold	10	–	–	﹤0.01%	312
2013 Q3	$2K	Sell	10 -7	-41%	-$1.57K	﹤0.01%	294
2013 Q2	$4K	Buy	+17	New	+$3.63K	﹤0.01%	265

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Edge Wealth Management's BIIB Position: Q1 2022 in Review

Edge Wealth Management sold out of Biogen (BIIB) in Q1 2022, closing a stake of 5 shares — an estimated $1K sold.

Edge Wealth Management first reported a position in BIIB in Q2 2013 and held it in 20 quarters. The position peaked at $82K in Q1 2018. 951 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.

Edge Wealth Management reported no remaining Biogen position as of Q1 2022 after selling out during the quarter.
Edge Wealth Management sold 5 Biogen shares in Q1 2022, an estimated $1K.
Edge Wealth Management first reported a position in Biogen in Q2 2013 and held it in 20 quarters.
Edge Wealth Management's Biogen position peaked at $82K in Q1 2018.
951 funds tracked by Wall St. Rank held Biogen as of Q1 2022.

Based on Edge Wealth Management's 13F filing for Q1 2022, filed 14 Apr 2022.